NeoPharm CO. LTD (092730)
KOSDAQ · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 22,300.00 |
|---|---|
| 52-week range | 15,590.00 – 26,000.00 |
| Return, 1 month / 3 months | −5.7% / +15.5% |
| Return, 1 year / 3 years | +31.6% / +105.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 45.2% |
| Worst drawdown (1 year) | -28.8% |
| Average daily value traded | 1,509.47M KRW |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
NeoPharm CO. LTD (092730) trades on the KOSDAQ in Korea. It last closed at KRW 22,300.00 on 27 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 7 of 1,833 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.6% and over the last three months it rose 15.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.3% | ||
| From 52-week high | -12.4% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.5% | ||
| 6-month return | 10.9% | ||
| 12-month return, skipping the last month | 39.5% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.8% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 1,509.47M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.4% |
|---|---|
| 1 month | −5.7% |
| 3 months | +15.5% |
| 6 months | +10.9% |
| 1 year | +31.6% |
| 3 years | +105.2% |
| 5 years | +93.9% |
Signals
| 50-day / 200-day average | 23,064.00 / 19,681.15 |
|---|---|
| Golden / death cross (60 days) | Golden, 51 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,141.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 750.0000 |
| 27 Dec 2024 | KRW 600.0000 |
| 27 Dec 2023 | KRW 750.0000 |
| 28 Dec 2022 | KRW 700.0000 |
| 29 Dec 2021 | KRW 700.0000 |
| 29 Dec 2020 | KRW 650.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.